1. Home
  2. CLLS vs BWFG Comparison

CLLS vs BWFG Comparison

Compare CLLS & BWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • BWFG
  • Stock Information
  • Founded
  • CLLS 1999
  • BWFG 2002
  • Country
  • CLLS France
  • BWFG United States
  • Employees
  • CLLS N/A
  • BWFG N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • BWFG Major Banks
  • Sector
  • CLLS Health Care
  • BWFG Finance
  • Exchange
  • CLLS Nasdaq
  • BWFG Nasdaq
  • Market Cap
  • CLLS 299.0M
  • BWFG 333.1M
  • IPO Year
  • CLLS 2007
  • BWFG N/A
  • Fundamental
  • Price
  • CLLS $3.15
  • BWFG $45.74
  • Analyst Decision
  • CLLS Buy
  • BWFG Buy
  • Analyst Count
  • CLLS 1
  • BWFG 2
  • Target Price
  • CLLS $4.00
  • BWFG $42.00
  • AVG Volume (30 Days)
  • CLLS 76.4K
  • BWFG 40.7K
  • Earning Date
  • CLLS 11-03-2025
  • BWFG 10-27-2025
  • Dividend Yield
  • CLLS N/A
  • BWFG 1.80%
  • EPS Growth
  • CLLS N/A
  • BWFG N/A
  • EPS
  • CLLS N/A
  • BWFG 2.64
  • Revenue
  • CLLS $63,438,000.00
  • BWFG $81,749,000.00
  • Revenue This Year
  • CLLS N/A
  • BWFG $66.56
  • Revenue Next Year
  • CLLS $66.76
  • BWFG $14.45
  • P/E Ratio
  • CLLS N/A
  • BWFG $16.83
  • Revenue Growth
  • CLLS 223.09
  • BWFG 0.32
  • 52 Week Low
  • CLLS $1.10
  • BWFG $26.39
  • 52 Week High
  • CLLS $3.35
  • BWFG $46.63
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 54.47
  • BWFG 71.31
  • Support Level
  • CLLS N/A
  • BWFG $44.03
  • Resistance Level
  • CLLS $3.35
  • BWFG $46.63
  • Average True Range (ATR)
  • CLLS 0.15
  • BWFG 1.01
  • MACD
  • CLLS -0.09
  • BWFG 0.13
  • Stochastic Oscillator
  • CLLS 94.03
  • BWFG 82.48

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About BWFG Bankwell Financial Group Inc.

Bankwell Financial Group Inc is a bank holding company, engaged in providing financial products and services. It offers products related to commercial lending, retail lending, depository services, and others. The bank's commercial lending products includes owner-occupied commercial real estate loans, commercial real estate investment loans, commercial loans to small and mid-sized businesses and real estate construction and development loans. The retail lending products include residential mortgage loans, home equity lines of credit, and consumer installment loans. Its depository products include checking, savings, money market, certificates of deposit, noninterest-bearing demand, and time deposits.

Share on Social Networks: